O-Xylene

O-Xylene

SCHEMBL2589554

Cc1ccccc1C.ClC(Cl)C(Cl)Cl

nearest known ligand 0.67

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 5/20 0.67
ACHE P22303 3/20 0.67
ALDH1A1 P00352 4/20 0.43
CA1 P00915 2/20 0.43
CA2 P00918 2/20 0.43
CA7 P43166 2/20 0.43
CA9 Q16790 2/20 0.43
ESR1 P03372 1/20 0.42
CYP3A4 P08684 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
CYP1A2 P05177 2/20 0.40
CYP2A6 P11509 2/20 0.40
LMNA P02545 1/20 0.37
ALOX12 P18054 1/20 0.37
MAPT P10636 1/20 0.36
HTT P42858 1/20 0.36
TAAR1 Q96RJ0 1/20 0.35
HSD17B10 Q99714 1/20 0.35
HSP90AA1 P07900 1/20 0.34
ATM Q13315 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
O-Xylene SCHEMBL2858075 0.90 TSHR (0.71) TSHRACHEALDH1A1CA1CA2
O-Xylene SCHEMBL10353038 0.87 TSHR (0.67) TSHRACHEALDH1A1CA1CA2
O-Xylene SCHEMBL6933035 0.82 TSHR (0.83) TSHRACHEALDH1A1CA1CA2
O-Xylene SCHEMBL2854068 0.82
O-Xylene SCHEMBL8216257 0.82 TSHR (1.00) TSHRACHEALDH1A1CA1CA2
O-Xylene SCHEMBL11035539 0.82 TSHR (1.00) TSHRACHEALDH1A1CA1CA2
O-Xylene SCHEMBL772 0.82
O-Xylene SCHEMBL10522915 0.82 TSHR (1.00) TSHRACHEALDH1A1CA1CA2
O-Xylene SCHEMBL11034038 0.82 TSHR (1.00) TSHRACHEALDH1A1CA1CA2
O-Xylene SCHEMBL170581 0.82 TSHR (1.00) TSHRACHEALDH1A1CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109689626-B Method for synthesizing near-infrared closed-chain sulfo-cyanine dye 直观外科手术操作公司 2022-11-08 CN disclosed
US-10759729-B2 Compounds for treating diabetes THE CHINESE UNIVERSITY OF HONG KONG (CN) 2020-09-01 US disclosed
EP-3481802-A1 METHOD OF SYNTHESIZING NEAR IR, CLOSED CHAIN SULFO-CYANINE DYES Intuitive Surgical Operations Inc. (US) 2019-05-15 EP disclosed
CN-109689626-A Synthesize near-infrared, closed chain sulfo group-cyanine dye method 直观外科手术操作公司 2019-04-26 CN disclosed
US-20180319987-A1 Method of Synthesizing Near IR, Closed Chain Sulfo-Cyanine Dyes Intuitive Surgical Operations, Inc. 2018-11-08 US disclosed
US-10053580-B2 Method of synthesizing near IR, closed chain sulfo-cyanine dyes Intuitive Surgical Operations, Inc. (US) 2018-08-21 US disclosed
CN-108059589-A Novel compounds for the treatment of diabetes 香港中文大学 2018-05-22 CN disclosed
US-20180127343-A1 NOVEL COMPOUNDS FOR TREATING DIABETES THE CHINESE UNIVERSITY OF HONG KONG (CN) 2018-05-10 US disclosed
US-20180009987-A1 Method of Synthesizing Near IR, Closed Chain Sulfo-Cyanine Dyes Intuitive Surgical Operations, Inc. (US) 2018-01-11 US disclosed
WO-2018009375-A1 METHOD OF SYNTHESIZING NEAR IR, CLOSED CHAIN SULFO-CYANINE DYES Intuitive Surgical Operations, Inc. (US) 2018-01-11 WO disclosed
US-9796854-B1 Method of synthesizing near IR, closed chain sulfo-cyanine dyes Intuitive Surgical Operations, Inc. (US) 2017-10-24 US disclosed
US-8722897-B2 Metal complexes of thiourea and derivatives as metal delivering anti-cancer and anti-inflammatory agents GOLDPORP PHARMA LIMITED (CN) 2014-05-13 US disclosed
US-20110269730-A1 Metal Complexes of Thiourea and Derivatives as Metal Delivering Anti-Cancer and Anti-Inflammatory Agents GOLDPORP PHARMA LIMITED (CN) 2011-11-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10759729-B2 Compounds for treating diabetes SLC5A2, GPR119, DPP4 TSHR 2084/4885ACHE 1563/4885ALDH1A1 481/4885
US-20180009987-A1 Method of Synthesizing Near IR, Closed Chain Sulfo-Cyanine Dyes SPR, IK, TST TSHR 1637/4885ACHE 2460/4885ALDH1A1 4291/4885
US-10053580-B2 Method of synthesizing near IR, closed chain sulfo-cyanine dyes SPR, IK, TST TSHR 1637/4885ACHE 2460/4885ALDH1A1 4291/4885
US-20110269730-A1 Metal Complexes of Thiourea and Derivatives as Metal Delivering Anti-Cancer and Anti-Inflammatory Agents CLIC1, SLC30A5, TIA1 TSHR 67/4885ACHE 2075/4885ALDH1A1 1053/4885
US-20180319987-A1 Method of Synthesizing Near IR, Closed Chain Sulfo-Cyanine Dyes SPR, IK, TST TSHR 1637/4885ACHE 2460/4885ALDH1A1 4291/4885
US-20180127343-A1 NOVEL COMPOUNDS FOR TREATING DIABETES GPR119, SLC5A2, DPP4 TSHR 2250/4885ACHE 2370/4885ALDH1A1 518/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.